Byron L. Dorgan - 11 Jun 2024 Form 4 Insider Report for CODEXIS, INC. (CDXS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 Jun 2024, 18:25:59 UTC
Prior SEC filing
17 Nov 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sriram Ryali, as Attorney-in-Fact for Byron Dorgan

Key filing fact

Byron L. Dorgan filed Form 4 for CODEXIS, INC. (CDXS) on 13 Jun 2024.

Key facts

  • This page summarizes Byron L. Dorgan's Form 4 filing for CODEXIS, INC. (CDXS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Jun 2024, 18:25.

Change

  • Previous filing in this sequence was filed on 17 Nov 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDXS transaction

Common Stock

Award

Transaction value
$0
Shares
+30,120
Change %
+16%
Price
$0.000000
Shares after
223,581
Date
11 Jun 2024
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .